Successful demonstration of reduced APAP toxicity, using synthetic TLR4 antagonists14, 18 and inhibitor of lipopolysaccharide-binding protein,19 have further strengthened the TLR4-LPS nexus in APAP-induced liver dysfunction. This evidence concerns the gene TLR4 and Decreased liver function.